News

DZHK Registry Shows How New Therapies Perform in Routine Clinical Practice

How does a new medicine perform once it is used in routine clinical practice following approval? This is the question the German Centre for…

Read more

Minimally Invasive Tricuspid Valve Repair Reduces Mortality and Hospitalisations

Study by the German Centre for Cardiovascular Research (DZHK), led by LMU University Hospital Munich, demonstrates for the first time benefits in hard…

Read more

From Cardiovascular Research to a Biotech Company: REVIER Therapeutics Launches with €6 Million

Heidelberg-based biotech company REVIER Therapeutics has officially launched. The company, which emerged from research conducted at the German Centre…

Read more

No Risk-Free Nicotine Use: International Research Team Maps the Biological Hierarchy Risks to the Cardiovascular System

A recent review led by University Medical Center Mainz compares the effects of cigarettes, waterpipes, heated tobacco products, e-cigarettes, and…

Read more

Obesity drug significantly reduces the risk of serious cardiovascular events and infections

People with type 2 diabetes and obesity may benefit from treatment with tirzepatide. Tirzepatide, marketed under the brand name Mounjaro, can reduce…

Read more

Detecting cardiomyopathies in the magnetic field

The MagMa study by the DHZC, involving DZHK researchers, shows for the first time in a prospective study that radiation-free magnetocardiography can…

Read more